期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Clinical Value of Vascular Endothelial Growth Factor Combined with Interferon-γ in Diagnosing Malignant Pleural Effusion and Tuberculous Pleural Effusion 被引量:6
1
作者 薛克营 熊盛道 熊维宁 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2007年第5期495-497,共3页
In order to investigate the clinical value of vascular endothelial growth factor(VEGF) combined with interferon-γ(IFN-γ) in diagnosing malignant pleural effusion and tuberculous pleural effusion,42 cases of malignan... In order to investigate the clinical value of vascular endothelial growth factor(VEGF) combined with interferon-γ(IFN-γ) in diagnosing malignant pleural effusion and tuberculous pleural effusion,42 cases of malignant pleural effusion and 45 cases of tuberculous pleural effusion in Tongji Hospital,from March 2004 to May 2005,were included.The carcinoembryonic antigen(CEA),VEGF and IFN-γ levels of pleural effusion were detected by using ELISA,and adenosine deaminase(ADA) activity was determined by using enzyme kinetic analytical method.The sensitivity,specificity,accuracy and area under the curve(AUCROC) of CEA and VEGF,VEGF/IFN-γ ratio,ADA and IFN-γ were measured by receiver operating characteristic curve(ROC).The results showed that CEA,VEGF levels and VEGF/IFN-γ ratio were significantly higher and the ADA and IFN-γ levels were significantly lower in malignant group than those in tuberculous group(P<0.01).The sensitivity,specificity,accuracy and AUCROC of VEGF/IFN-γ ratio(88.7%,99.8%,94.4%,0.96 respectively) were higher than those of CEA(67.8%,96.1%,82.4%,0.78 respectively) and VEGF(81.5%,84.3%,82.9%,0.79 respectively).The sensitivity,specificity,accuracy and AUCROC of IFN-γ(85.7%,96.4%,90.9%,0.94 respectively) were higher than those of ADA(80.2%,87.6%,83.8%,0.81 respectively).It was concluded that VEGF/IFN-γ ratio and IFN-γ could be used as valuable parameters for the differential diagnosis of malignant pleural effusion and tuberculous pleural effusion. 展开更多
关键词 血管内皮生长因子 干扰素-Γ 恶性胸膜渗出 结核性胸膜渗出 诊断
下载PDF
Clinical Observation on the Efficacy of Xiaoshui Decoction (消水方) Combined with Intrapleural Perfusion of Cisplatin in Treating Malignant Pleural Effusion 被引量:2
2
作者 施展 何庆勇 花宝金 《Chinese Journal of Integrative Medicine》 SCIE CAS 2008年第4期257-261,共5页
观察 Xiaoshui 煎的临床的功效的目的(XSD,消水方) 在恶意的胸膜渗漏的处理与 cisplatin 的胸膜内灌注结合了。有恶意的胸膜渗漏的 51 个病人随机被分到二个组的方法。XSD 的收到的口服与 cisplatin 的胸膜内灌注相结合的对待的组(26 ... 观察 Xiaoshui 煎的临床的功效的目的(XSD,消水方) 在恶意的胸膜渗漏的处理与 cisplatin 的胸膜内灌注结合了。有恶意的胸膜渗漏的 51 个病人随机被分到二个组的方法。XSD 的收到的口服与 cisplatin 的胸膜内灌注相结合的对待的组(26 个病人) ,和控制组(25 个病人) 是仅仅与胸膜内对待 cisplatin 的灌注。短期的功效,生活分数的质量和恶意的胸膜渗漏的临床的症状分数的效果被评估。结果分别地,在对待的组和控制组的短期的功效是 72.0% 和 58.3% ,没有有效差量被发现 P】0.05 ) 。相反,在对待的组的生命的质量显著地与控制组(P【0.05 ) 的相比被改进,那么是症状宽恕(P【0.05 ) 。XSD 的联合治疗和 cisplatin 的胸膜内灌注没在短期的功效看明显的改进的结论,而是治疗显著地减轻了症状并且改进了病人的生命的质量。 展开更多
关键词 消水方 恶性胸膜渗出 临床效果 治疗方法
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部